Abstract
Purpose
Liquid-chromatography tandem mass-spectrometry (LC-MS/MS) was developed in parallel to Immunoassays (IAs) and today is proposed as the “gold standard” for steroid assays. Leydig cells of men with Klinefelter syndrome (KS) are able to respond to human chorionic gonadotropin (hCG) stimulation, even if testosterone (T) production was impaired. The aim was to evaluate how results obtained by IAs and LC-MS/MS can differently impact on the outcome of a clinical research on gonadal steroidogenesis after hCG stimulation.
Methods
A longitudinal, prospective, case-control clinical trial. (clinicaltrial.gov NCT02788136) was carried out, enrolling KS men and healthy age-matched controls, stimulated by hCG administration. Serum steroids were evaluated at baseline and for 5 days after intramuscular injection of 5000 IU hCG using both IAs and LC-MS/MS.
Results
13 KS patients (36 ± 9 years) not receiving T replacement therapy and 14 controls (32 ± 8 years) were enrolled. T, progesterone, cortisol, 17-hydroxy-progesterone (17OHP) and androstenedione, were significantly higher using IAs than LC-MS/MS. IAs and LC-MS/MS showed direct correlation for all five steroids, although the constant overestimation detected by IAs. Either methodology found the same 17OHP and T increasing profile after hCG stimulation, with equal areas under the curves (AUCs).
Conclusions
Although a linearity between IA and LC-MS/MS is demonstrated, LC-MS/MS is more sensitive and accurate, whereas IA shows a constant overestimation of sex steroid levels. This result suggests the need of reference intervals built on the specific assay. This fundamental difference between these two methodologies opens a deep reconsideration of what is needed to improve the accuracy of steroid hormone assays.
Similar content being viewed by others
References
Taylor AE, Keevil B, Huhtaniemi IT (2015) Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow. Eur J Endocrinol Eur Fed Endocr Soc 173(2):D1–D12. doi:10.1530/eje-15-0338
Schoenheimer R, Rittenberg D (1935) Deuterium as an indicator in the study of intermediary metabolism. Science 82(2120):156–157. doi:10.1126/science.82.2120.156
Shackleton C (2010) Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis. J Steroid Biochem Mol Biol 121(3–5):481–490. doi:10.1016/j.jsbmb.2010.02.017
Handelsman DJ, Wartofsky L (2013) Requirement for mass spectrometry sex steroid assays in the journal of clinical endocrinology metabolism. J Clin Endocrinol Metab 98(10):3971–3973. doi:10.1210/jc.2013-3375
Wierman ME, Auchus RJ, Haisenleder DJ, Hall JE, Handelsman D, Hankinson S, Rosner W, Singh RJ, Sluss PM, Stanczyk FZ (2014) Editorial: the new instructions to authors for the reporting of steroid hormone measurements. J Clin Endocrinol Metab 99(12):4375. doi:10.1210/jc.2014-3424
Monaghan PJ, Keevil BG, Stewart PM, Trainer PJ (2014) Case for the wider adoption of mass spectrometry-based adrenal steroid testing, and beyond. J Clin Endocrinol Metab 99(12):4434–4437. doi:10.1210/jc.2014-2258
Botelho JC, Shacklady C, Cooper HC, Tai SS, Van Uytfanghe K, Thienpont LM, Vesper HW (2013) Isotope-dilution liquid chromatography-tandem mass spectrometry candidate reference method for total testosterone in human serum. Clin Chem 59(2):372–380. doi:10.1373/clinchem.2012.190934
Hoofnagle AN, Wener MH (2009) The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J Immunol Methods 347(1–2):3–11. doi:10.1016/j.jim.2009.06.003
Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92(2):405–413. doi:10.1210/jc.2006-1864
Fanelli F, Belluomo I, Di Lallo VD, Cuomo G, De Iasio R, Baccini M, Casadio E, Casetta B, Vicennati V, Gambineri A, Grossi G, Pasquali R, Pagotto U (2011) Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. Steroids 76(3):244–253. doi:10.1016/j.steroids.2010.11.005
Simoni M, Fanelii F, Roli L UP (2012) Methodology for measuring testosterone, dihydrotestosterone and sex-hormone-binding globulin in a clinical setting. In: Nieschlag E, HBehre HM (eds) Testosterone, vol 4. Cambridge
Buttler RM, Martens F, Fanelli F, Pham HT, Kushnir MM, Janssen MJ, Owen L, Taylor AE, Soeborg T, Blankenstein MA, Heijboer AC (2015) Comparison of 7 published LC-MS/MS methods for the simultaneous measurement of testosterone, androstenedione, and dehydroepiandrosterone in serum. Clin Chem 61(12):1475–1483. doi:10.1373/clinchem.2015.242859
Owen LJ, Wu F, Buttler R, Keevil BG (2015) Annals express: a direct assay for the routine measurement of testosterone, androstenedione, dihydrotestosterone and dehydroepiandrosterone by LC-MS/MS. Ann Clin Biochem. doi:10.1177/0004563215621096
Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E (2004) Klinefelter’s syndrome. Lancet (London, England) 364(9430):273–283. doi:10.1016/s0140-6736(04)16678-6
Bonomi M, Rochira V, Pasquali D, Balercia G, Jannini EA, Ferlin A (2017) Klinefelter syndrome (KS): genetics, clinical phenotype and hypogonadism. J Endocrinol Invest 40(2):123–134. doi:10.1007/s40618-016-0541-6
Aksglaede L, Juul A (2013) Testicular function and fertility in men with Klinefelter syndrome: a review. Eur J Endocrinol Eur Fed Endocr Soc 168(4):R67–R76. doi:10.1530/eje-12-0934
Host C, Skakkebaek A, Groth KA, Bojesen A (2014) The role of hypogonadism in Klinefelter syndrome. Asian J Androl 16(2):185–191. doi:10.4103/1008-682x.122201
Belli S, Santi D, Leoni E, Dall’Olio E, Fanelli F, Mezzullo M, Pelusi C, Roli L, Tagliavini S, Trenti T, Granata ARM, Pagotto U, Pasquali R, Rochira V, Carani C, Simoni M (2016) Human chorionic gonadotropin stimulation gives evidence of differences in testicular steroidogenesis in Klinefelter syndrome, as assessed by liquid chromatography–tandem mass spectrometry. Eur J Endocrinol 174:1–11. doi:10.1530/EJE-15-1224
Passing H, Bablok (1983) A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem Zeitschrift fur klinische Chemie klinische Biochemie 21(11):709–720
Bland JM, Altman DG (1999) Measuring agreement in method comparison studies. Stat Methods Med Res 8(2):135–160
Bilic-Zulle L (2011) Comparison of methods: passing and bablok regression. Biochem Med 21(1):49–52
Fitzgerald RL, Herold DA (1996) Serum total testosterone: immunoassay compared with negative chemical ionization gas chromatography-mass spectrometry. Clin Chem 42(5):749–755
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95(6):2536–2559. doi:10.1210/jc.2009-2354
Lunenfeld B, Mskhalaya G, Kalinchenko S, Tishova Y (2013) Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men - a suggested update. Aging Male Off J Int Soc Study Aging Male 16(4):143–150. doi:10.3109/13685538.2013.853731
Teede H, Deeks A, Moran L (2010) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 8:41. doi:10.1186/1741-7015-8-41
Tosi F, Fiers T, Kaufman JM, Dall’Alda M, Moretta R, Giagulli VA, Bonora E, Moghetti P (2015) Implications of androgen assay accuracy in the phenotyping of women with polycystic ovary syndrome. J Clin Endocrinol Metab jc20152807. doi:10.1210/jc.2015-2807
Farquhar C, Rishworth JR, Brown J, Nelen WL, Marjoribanks J (2014) Assisted reproductive technology: an overview of Cochrane reviews. Cochrane Database System Rev 12:CD010537. doi:10.1002/14651858.CD010537.pub3
Fauser BC, Devroey P, Macklon NS (2005) Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet (London, England) 365(9473):1807–1816. doi:10.1016/s0140-6736(05)66478-1
Schuring AN, Kelsch R, Pierscinski G, Nofer JR (2016) Establishing reference intervals for sex hormones on the analytical platforms advia centaur and immulite 2000XP. Ann Lab Med 36(1):55–59. doi:10.3343/alm.2016.36.1.55
Acknowledgements
DS is a PhD fellow of the Doctorate School in Clinical and Experimental Medicine of the University of Modena and Reggio Emilia, Italy. LC-MS/MS assays were performed thanks to Emilia-Romagna Region, Alessandro Liberati Young Researcher Grants, PRUA 1-2012-004.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Ethical approval
The study protocol was approved by the Ethics Committee of Modena (File nr. 04/12).
Informed consent
Written informed consent was obtained from all participants.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Roli, L., Santi, D., Belli, S. et al. The steroid response to human chorionic gonadotropin (hCG) stimulation in men with Klinefelter syndrome does not change using immunoassay or mass spectrometry. J Endocrinol Invest 40, 841–850 (2017). https://doi.org/10.1007/s40618-017-0653-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-017-0653-7